Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2013
08/20/2013CA2440358C Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
08/15/2013WO2013120066A1 Chemoenzymatic glycoengineering of antibodies and fc fragments thereof
08/15/2013WO2013120012A2 Cdim binding proteins and uses thereof
08/15/2013WO2013119966A2 Single-chain antibodies and other heteromultimers
08/15/2013WO2013119716A1 Compositions and methods for using csf1r inhibitors
08/15/2013WO2013119693A1 Emp2 regulates angiogenesis in cancer cells through induction of vegf
08/15/2013WO2013119419A1 Treatment of allergic diseases with recombinant antibodies
08/15/2013WO2013117912A1 Sheep nematode vaccine
08/15/2013WO2013117735A1 Conjugate comprising an agent and an antiviral ligand and its use in a method for delivering the agent intracellularly
08/15/2013WO2013117647A1 Mica binding agents
08/15/2013WO2013117591A1 Method for linking and characterising linked nucleic acids, e.g. antibody encoding nucleic acids, in a composition
08/15/2013WO2013093122A3 Antibodies for the treatment and diagnosis of affective and anxiety disorders
08/15/2013WO2013084148A3 Antibodies for epidermal growth factor receptor 3 (her3) directed to domain ii of her3
08/15/2013WO2013082463A3 Assays, antibodies, immunogens and compositions related to 5-fu
08/15/2013WO2013006544A8 Methods for making multimeric polypeptides
08/15/2013WO2012156975A9 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
08/15/2013WO2011140249A3 Antibodies that bind csf1r
08/15/2013US20130211052 Lenalidomide and Thalidomide Immunoassays
08/15/2013US20130211051 Fusion protein containing vegi, and pharmaceutical composition and use thereof
08/15/2013US20130211050 Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
08/15/2013US20130211049 Immunotoxin fusion proteins and means for expression thereof
08/15/2013US20130210137 Methods of Modifying Eukaryotic Cells
08/15/2013US20130210116 Composition and methods for the diagnosis and treatment of tumor
08/15/2013US20130210075 Enhanced protein expression
08/15/2013US20130210004 Egfr-related polypeptides and methods of use
08/15/2013US20130209635 Plants which synthesize a modified starch, process for the production thereof and modified starch
08/15/2013US20130209497 Whole egg protein peptides, preparation method and use thereof
08/15/2013US20130209495 ErbB3 ANTIBODIES
08/15/2013US20130209494 Enediyne compounds, conjugates thereof, and uses and methods therefor
08/15/2013US20130209492 Anti-Tie2 Antibodies and Uses Thereof
08/15/2013US20130209491 Methods of generating antibodies to metalloenzymes
08/15/2013US20130209489 Antibodies That Bind Myostatin, Compositions And Methods
08/15/2013US20130209482 Monoclonal antibodies to basic fibroblast growth factor
08/15/2013US20130209481 Anti-Tumor Antigen Antibodies and Methods of Use
08/15/2013US20130209478 Formulation comprising an antibody against p-selectin
08/15/2013US20130209475 Dkk1 antibodies and methods of use
08/15/2013US20130209474 Wise/sost nucleic acid sequences and amino acid sequences
08/15/2013US20130209471 Dc-stamp antibodies
08/15/2013US20130209470 Antibodies that bind both il-17a and il-17f and methods of using the same
08/15/2013US20130209469 Antibodies that bind il-4 and/or il-13 and their uses
08/15/2013US20130209466 Compositions and methods for producing bioactive fusion proteins
08/15/2013US20130209464 Polypeptides having antiviral activity and methods for use thereof
08/15/2013US20130209459 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
08/15/2013US20130209458 Fab-glycosylated antibodies
08/15/2013US20130209457 Optimized Fc Variants
08/15/2013US20130209456 Subtypes of humanized antibody against interleukin-6 receptor
08/15/2013US20130209455 Humanized Anti-CDCP1 Antibodies
08/15/2013US20130209454 Anti-hiv antibodies having increased potency and breadth
08/15/2013US20130209451 Treatments for Cancer
08/15/2013US20130209449 Anti-psgl-1 antibodies and uses thereof
08/15/2013US20130209445 Optimized Fc Variants
08/15/2013US20130209365 Anti-C-Met Antibody and Methods of Use Thereof
08/15/2013US20130209355 Antibodies against human cd38
08/14/2013EP2626425A1 Influenza virus neutralizing antibody and method for screening same
08/14/2013EP2626418A1 Method for activating helper t cell
08/14/2013EP2626372A1 Bispecific antibodies and methods for production thereof
08/14/2013EP2626371A1 Multispecific epitope binding proteins and uses thereof
08/14/2013EP2626370A1 Immunogenic compositions containing Escherichia coli H7 flagella and methods of use thereof
08/14/2013EP2626358A1 Immunoassay for pyrrolidinophenones
08/14/2013EP2625281A2 Cyanine compounds, conjugates and method of use
08/14/2013EP2625205A2 Antibody targeting osteoclast-related protein siglec-15
08/14/2013EP2625204A1 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor
08/14/2013EP2625203A1 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
08/14/2013EP2625202A1 A new method for diagnosing hypertension as well as cardiomyopathies
08/14/2013EP2625201A1 Cd33 binding agents
08/14/2013EP2625200A1 Antibodies against human tweak and uses thereof
08/14/2013EP2625199A1 Methods of treating psoriasis using il-17 antagonists
08/14/2013EP2625198A2 Pharmaceutical composition
08/14/2013EP2624868A2 A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
08/14/2013EP2624866A2 Tumor specific antibodies and uses therefor
08/14/2013EP2624865A1 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
08/14/2013EP2624861A1 Malaria vaccine
08/14/2013EP2624857A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
08/14/2013EP2624844A1 Methods and compositions using anti-lps ligands for the treatment and prevention of inflammatory disorders
08/14/2013EP2149585B1 Use of antagonistic anti-CD40 monoclonal antibodies
08/14/2013CN103249833A Human monoclonal antibody
08/14/2013CN103249742A Anti-hutnfr1 antibody
08/14/2013CN103249432A Antibodies to the c3d fragment of complement component 3
08/14/2013CN103243119A Expression and preparation method of soluble CD83
08/14/2013CN103243077A Avian leukosis P27 monoclonal antibody hybridoma cell strain and application thereof
08/14/2013CN103242451A Multivalent immunoglobulin-based bioactive assemblies
08/14/2013CN103242450A Preparation method of anti-florfenicol amine IgY (egg yolk immunoglobulin)
08/14/2013CN103242449A Monoclonal antibody of grass carp immune globulin and preparation method and use thereof
08/14/2013CN103242448A Full-humanized anti-PD-1 monoclonal antibody and preparation method and application thereof
08/14/2013CN103242447A Tweak binding antibodies
08/14/2013CN103242446A Theophylline immunogen and preparation method and application thereof
08/14/2013CN103242445A Valproic acid immunogen and preparation method and application thereof
08/14/2013CN103242433A Adenovirus non-structural protein immunogen, antibody and applications thereof
08/14/2013CN103242428A Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
08/14/2013CN102718855B Anti-Pf 332-DBL sectional monoclonal antibody capable of inhibiting invasion of plasmodium falciparum
08/14/2013CN102146137B Antibody to beta-amyloid peptide and application thereof
08/14/2013CN101970500B Anti-tyrp1 antibodies
08/14/2013CN101802006B Display of binding agents
08/14/2013CN101646691B Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen
08/14/2013CN101420978B Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies
08/14/2013CN101346153B Immunoglobulin G (IGG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IGGS
08/14/2013CN101068836B Anti-glypican 3 antibody having modified sugar chain
08/13/2013US8507748 Method for the production of a single heavy chain antibody
08/13/2013US8507658 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
08/13/2013US8507657 Anti-GD2 antibodies
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 1494